UniProt ID | RPN1_HUMAN | |
---|---|---|
UniProt AC | P04843 | |
Protein Name | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | |
Gene Name | RPN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 607 | |
Subcellular Localization |
Endoplasmic reticulum . Endoplasmic reticulum membrane Single-pass type I membrane protein . Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
|
Protein Description | Essential subunit of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains.. | |
Protein Sequence | MEAPAAGLFLLLLLGTWAPAPGSASSEAPPLINEDVKRTVDLSSHLAKVTAEVVLAHLGGGSTSRATSFLLALEPELEARLAHLGVQVKGEDEEENNLEVRETKIKGKSGRFFTVKLPVALDPGAKISVIVETVYTHVLHPYPTQITQSEKQFVVFEGNHYFYSPYPTKTQTMRVKLASRNVESYTKLGNPTRSEDLLDYGPFRDVPAYSQDTFKVHYENNSPFLTITSMTRVIEVSHWGNIAVEENVDLKHTGAVLKGPFSRYDYQRQPDSGISSIRSFKTILPAAAQDVYYRDEIGNVSTSHLLILDDSVEMEIRPRFPLFGGWKTHYIVGYNLPSYEYLYNLGDQYALKMRFVDHVFDEQVIDSLTVKIILPEGAKNIEIDSPYEISRAPDELHYTYLDTFGRPVIVAYKKNLVEQHIQDIVVHYTFNKVLMLQEPLLVVAAFYILFFTVIIYVRLDFSITKDPAAEARMKVACITEQVLTLVNKRIGLYRHFDETVNRYKQSRDISTLNSGKKSLETEHKALTSEIALLQSRLKTEGSDLCDRVSEMQKLDAQVKELVLKSAVEAERLVAGKLKKDTYIENEKLISGKRQELVTKIDHILDAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
37 | Ubiquitination | PLINEDVKRTVDLSS CCCCCCHHHHHHHHH | 55.46 | - | |
39 | Phosphorylation | INEDVKRTVDLSSHL CCCCHHHHHHHHHHH | 16.80 | 21406692 | |
43 | Phosphorylation | VKRTVDLSSHLAKVT HHHHHHHHHHHHHHH | 15.96 | 21406692 | |
44 | Phosphorylation | KRTVDLSSHLAKVTA HHHHHHHHHHHHHHH | 29.80 | 21406692 | |
48 | Ubiquitination | DLSSHLAKVTAEVVL HHHHHHHHHHHHHHH | 46.62 | - | |
50 | O-linked_Glycosylation | SSHLAKVTAEVVLAH HHHHHHHHHHHHHHH | 19.18 | OGP | |
62 | Phosphorylation | LAHLGGGSTSRATSF HHHCCCCCHHHHHHH | 26.87 | 24719451 | |
63 | Phosphorylation | AHLGGGSTSRATSFL HHCCCCCHHHHHHHH | 26.05 | 28348404 | |
64 | Phosphorylation | HLGGGSTSRATSFLL HCCCCCHHHHHHHHH | 22.93 | 26437602 | |
67 | Phosphorylation | GGSTSRATSFLLALE CCCHHHHHHHHHHHC | 20.92 | 30087585 | |
68 | Phosphorylation | GSTSRATSFLLALEP CCHHHHHHHHHHHCH | 16.95 | 30087585 | |
89 | Ubiquitination | AHLGVQVKGEDEEEN HHCCCEECCCCCCCC | 39.22 | 16196087 | |
108 | Ubiquitination | RETKIKGKSGRFFTV EEEEEECCCCCEEEE | 44.74 | 24816145 | |
116 | Ubiquitination | SGRFFTVKLPVALDP CCCEEEEEEEEEECC | 43.97 | 23000965 | |
135 | Phosphorylation | SVIVETVYTHVLHPY EEEEEEHHHCCCCCC | 9.88 | - | |
136 | Phosphorylation | VIVETVYTHVLHPYP EEEEEHHHCCCCCCC | 10.94 | - | |
144 | O-linked_Glycosylation | HVLHPYPTQITQSEK CCCCCCCCCCCCCCC | 27.10 | OGP | |
151 | Ubiquitination | TQITQSEKQFVVFEG CCCCCCCCEEEEEEC | 55.04 | 16196087 | |
155 | Ubiquitination | QSEKQFVVFEGNHYF CCCCEEEEEECCEEE | 3.69 | 21890473 | |
161 | Phosphorylation | VVFEGNHYFYSPYPT EEEECCEEEECCCCC | 14.28 | 28152594 | |
163 | Phosphorylation | FEGNHYFYSPYPTKT EECCEEEECCCCCCC | 11.11 | 28152594 | |
164 | Phosphorylation | EGNHYFYSPYPTKTQ ECCEEEECCCCCCCC | 14.20 | 28152594 | |
166 | Phosphorylation | NHYFYSPYPTKTQTM CEEEECCCCCCCCEE | 20.00 | 28152594 | |
168 | Phosphorylation | YFYSPYPTKTQTMRV EEECCCCCCCCEEEE | 40.66 | 28152594 | |
176 | Ubiquitination | KTQTMRVKLASRNVE CCCEEEEEEHHCCHH | 28.15 | 27667366 | |
184 | Phosphorylation | LASRNVESYTKLGNP EHHCCHHHHHCCCCC | 33.54 | 28152594 | |
185 | Phosphorylation | ASRNVESYTKLGNPT HHCCHHHHHCCCCCC | 8.39 | 26437602 | |
186 | Phosphorylation | SRNVESYTKLGNPTR HCCHHHHHCCCCCCC | 29.13 | 28152594 | |
187 | 2-Hydroxyisobutyrylation | RNVESYTKLGNPTRS CCHHHHHCCCCCCCC | 46.28 | - | |
187 | Acetylation | RNVESYTKLGNPTRS CCHHHHHCCCCCCCC | 46.28 | 19608861 | |
187 | Malonylation | RNVESYTKLGNPTRS CCHHHHHCCCCCCCC | 46.28 | 26320211 | |
187 | Ubiquitination | RNVESYTKLGNPTRS CCHHHHHCCCCCCCC | 46.28 | 27667366 | |
194 | Phosphorylation | KLGNPTRSEDLLDYG CCCCCCCCHHHHHCC | 37.63 | 21712546 | |
200 | Phosphorylation | RSEDLLDYGPFRDVP CCHHHHHCCCCCCCC | 27.03 | 28152594 | |
209 | Phosphorylation | PFRDVPAYSQDTFKV CCCCCCCCCCCCEEE | 10.78 | 28152594 | |
210 | Phosphorylation | FRDVPAYSQDTFKVH CCCCCCCCCCCEEEE | 24.56 | 28152594 | |
213 | Phosphorylation | VPAYSQDTFKVHYEN CCCCCCCCEEEEECC | 20.09 | 28152594 | |
215 | Ubiquitination | AYSQDTFKVHYENNS CCCCCCEEEEECCCC | 30.14 | 21906983 | |
222 | Phosphorylation | KVHYENNSPFLTITS EEEECCCCCCEEEEE | 28.72 | - | |
226 | Ubiquitination | ENNSPFLTITSMTRV CCCCCCEEEEEEEEE | 23.69 | 21890473 | |
228 | O-linked_Glycosylation | NSPFLTITSMTRVIE CCCCEEEEEEEEEEE | 13.75 | OGP | |
231 | O-linked_Glycosylation | FLTITSMTRVIEVSH CEEEEEEEEEEEEEC | 22.88 | OGP | |
254 | Ubiquitination | NVDLKHTGAVLKGPF CCCCCCCCCEEECCC | 17.26 | 21890473 | |
258 | Ubiquitination | KHTGAVLKGPFSRYD CCCCCEEECCCCCCC | 58.92 | 23000965 | |
264 | Phosphorylation | LKGPFSRYDYQRQPD EECCCCCCCCCCCCC | 20.15 | - | |
266 | Phosphorylation | GPFSRYDYQRQPDSG CCCCCCCCCCCCCCC | 9.17 | - | |
272 | Phosphorylation | DYQRQPDSGISSIRS CCCCCCCCCCCHHHH | 44.71 | 21406692 | |
275 | Phosphorylation | RQPDSGISSIRSFKT CCCCCCCCHHHHHCH | 24.20 | 24719451 | |
276 | Phosphorylation | QPDSGISSIRSFKTI CCCCCCCHHHHHCHH | 21.79 | 25954137 | |
281 | 2-Hydroxyisobutyrylation | ISSIRSFKTILPAAA CCHHHHHCHHHHHHH | 35.58 | - | |
281 | Ubiquitination | ISSIRSFKTILPAAA CCHHHHHCHHHHHHH | 35.58 | 21890473 | |
292 | Phosphorylation | PAAAQDVYYRDEIGN HHHHCCCEECCCCCC | 10.89 | 28152594 | |
293 | Phosphorylation | AAAQDVYYRDEIGNV HHHCCCEECCCCCCC | 16.07 | 28152594 | |
297 | Ubiquitination | DVYYRDEIGNVSTSH CCEECCCCCCCCCCE | 5.95 | 21890473 | |
299 | N-linked_Glycosylation | YYRDEIGNVSTSHLL EECCCCCCCCCCEEE | 30.17 | 19159218 | |
320 | Ubiquitination | EMEIRPRFPLFGGWK EEEECCCCCCCCCCE | 7.36 | 21890473 | |
352 | Ubiquitination | LGDQYALKMRFVDHV CCCCHHHHHHHCCCC | 21.62 | 21906983 | |
367 | O-linked_Glycosylation | FDEQVIDSLTVKIIL CCHHHHHEEEEEEEC | 18.15 | 23301498 | |
371 | Ubiquitination | VIDSLTVKIILPEGA HHHEEEEEEECCCCC | 20.85 | 21906983 | |
379 | 2-Hydroxyisobutyrylation | IILPEGAKNIEIDSP EECCCCCCCCEECCC | 70.12 | - | |
379 | Ubiquitination | IILPEGAKNIEIDSP EECCCCCCCCEECCC | 70.12 | 21906983 | |
385 | Phosphorylation | AKNIEIDSPYEISRA CCCCEECCCCCCCCC | 34.73 | 28152594 | |
387 | Phosphorylation | NIEIDSPYEISRAPD CCEECCCCCCCCCCC | 29.82 | 28152594 | |
390 | Phosphorylation | IDSPYEISRAPDELH ECCCCCCCCCCCCCE | 15.51 | 28152594 | |
391 | Ubiquitination | DSPYEISRAPDELHY CCCCCCCCCCCCCEE | 56.66 | 21890473 | |
398 | Phosphorylation | RAPDELHYTYLDTFG CCCCCCEEEEECCCC | 15.09 | - | |
399 | Phosphorylation | APDELHYTYLDTFGR CCCCCEEEEECCCCC | 13.58 | - | |
410 | Ubiquitination | TFGRPVIVAYKKNLV CCCCEEEEEECCCHH | 4.92 | 21890473 | |
412 | Phosphorylation | GRPVIVAYKKNLVEQ CCEEEEEECCCHHHH | 16.17 | 28152594 | |
413 | Acetylation | RPVIVAYKKNLVEQH CEEEEEECCCHHHHH | 26.00 | 26051181 | |
413 | Ubiquitination | RPVIVAYKKNLVEQH CEEEEEECCCHHHHH | 26.00 | 21906983 | |
414 | Acetylation | PVIVAYKKNLVEQHI EEEEEECCCHHHHHH | 42.72 | 156415 | |
414 | Ubiquitination | PVIVAYKKNLVEQHI EEEEEECCCHHHHHH | 42.72 | - | |
418 | Ubiquitination | AYKKNLVEQHIQDIV EECCCHHHHHHHHHH | 39.34 | 21890473 | |
452 | Ubiquitination | AFYILFFTVIIYVRL HHHHHHHHHHHHHHC | 11.94 | 21890473 | |
465 | Ubiquitination | RLDFSITKDPAAEAR HCCCCCCCCHHHHHH | 61.11 | 21906983 | |
474 | Ubiquitination | PAAEARMKVACITEQ HHHHHHHHHHHHHHH | 22.56 | - | |
477 | S-nitrosocysteine | EARMKVACITEQVLT HHHHHHHHHHHHHHH | 4.41 | - | |
477 | Glutathionylation | EARMKVACITEQVLT HHHHHHHHHHHHHHH | 4.41 | 22555962 | |
477 | S-nitrosylation | EARMKVACITEQVLT HHHHHHHHHHHHHHH | 4.41 | 20140087 | |
477 | S-palmitoylation | EARMKVACITEQVLT HHHHHHHHHHHHHHH | 4.41 | 29575903 | |
488 | 2-Hydroxyisobutyrylation | QVLTLVNKRIGLYRH HHHHHHHHHHCCHHH | 37.60 | - | |
488 | Acetylation | QVLTLVNKRIGLYRH HHHHHHHHHHCCHHH | 37.60 | 25953088 | |
488 | Ubiquitination | QVLTLVNKRIGLYRH HHHHHHHHHHCCHHH | 37.60 | 21906983 | |
504 | Ubiquitination | DETVNRYKQSRDIST HHHHHHHHHHCCHHH | 38.26 | 21890473 | |
510 | Phosphorylation | YKQSRDISTLNSGKK HHHHCCHHHHHHCCC | 31.00 | 21815630 | |
511 | Phosphorylation | KQSRDISTLNSGKKS HHHCCHHHHHHCCCC | 30.23 | 24719451 | |
514 | Phosphorylation | RDISTLNSGKKSLET CCHHHHHHCCCCHHH | 55.92 | 21815630 | |
516 | 2-Hydroxyisobutyrylation | ISTLNSGKKSLETEH HHHHHHCCCCHHHHH | 38.72 | - | |
516 | Acetylation | ISTLNSGKKSLETEH HHHHHHCCCCHHHHH | 38.72 | 26051181 | |
516 | Malonylation | ISTLNSGKKSLETEH HHHHHHCCCCHHHHH | 38.72 | 26320211 | |
516 | Ubiquitination | ISTLNSGKKSLETEH HHHHHHCCCCHHHHH | 38.72 | 27667366 | |
517 | Ubiquitination | STLNSGKKSLETEHK HHHHHCCCCHHHHHH | 64.89 | 29967540 | |
518 | Phosphorylation | TLNSGKKSLETEHKA HHHHCCCCHHHHHHH | 34.62 | 26657352 | |
521 | Phosphorylation | SGKKSLETEHKALTS HCCCCHHHHHHHHHH | 49.00 | 28102081 | |
524 | Acetylation | KSLETEHKALTSEIA CCHHHHHHHHHHHHH | 38.57 | 23954790 | |
524 | Malonylation | KSLETEHKALTSEIA CCHHHHHHHHHHHHH | 38.57 | 26320211 | |
524 | Ubiquitination | KSLETEHKALTSEIA CCHHHHHHHHHHHHH | 38.57 | 29967540 | |
527 | Phosphorylation | ETEHKALTSEIALLQ HHHHHHHHHHHHHHH | 29.22 | 25693802 | |
527 | Ubiquitination | ETEHKALTSEIALLQ HHHHHHHHHHHHHHH | 29.22 | 21890473 | |
528 | Phosphorylation | TEHKALTSEIALLQS HHHHHHHHHHHHHHH | 28.05 | 21712546 | |
535 | Phosphorylation | SEIALLQSRLKTEGS HHHHHHHHHHHHCCC | 39.28 | 30266825 | |
538 | 2-Hydroxyisobutyrylation | ALLQSRLKTEGSDLC HHHHHHHHHCCCHHH | 43.34 | - | |
538 | Acetylation | ALLQSRLKTEGSDLC HHHHHHHHHCCCHHH | 43.34 | 23749302 | |
538 | Malonylation | ALLQSRLKTEGSDLC HHHHHHHHHCCCHHH | 43.34 | 26320211 | |
538 | Sumoylation | ALLQSRLKTEGSDLC HHHHHHHHHCCCHHH | 43.34 | 25114211 | |
538 | Ubiquitination | ALLQSRLKTEGSDLC HHHHHHHHHCCCHHH | 43.34 | 27667366 | |
542 | Phosphorylation | SRLKTEGSDLCDRVS HHHHHCCCHHHHHHH | 22.60 | 23312004 | |
545 | Glutathionylation | KTEGSDLCDRVSEMQ HHCCCHHHHHHHHHH | 3.64 | 22555962 | |
547 | Methylation | EGSDLCDRVSEMQKL CCCHHHHHHHHHHHH | 32.63 | 115492375 | |
553 | Acetylation | DRVSEMQKLDAQVKE HHHHHHHHHHHHHHH | 47.20 | 23954790 | |
553 | Malonylation | DRVSEMQKLDAQVKE HHHHHHHHHHHHHHH | 47.20 | 26320211 | |
553 | Ubiquitination | DRVSEMQKLDAQVKE HHHHHHHHHHHHHHH | 47.20 | 23000965 | |
555 | Ubiquitination | VSEMQKLDAQVKELV HHHHHHHHHHHHHHH | 41.83 | 21890473 | |
559 | 2-Hydroxyisobutyrylation | QKLDAQVKELVLKSA HHHHHHHHHHHHHHH | 33.00 | - | |
559 | Acetylation | QKLDAQVKELVLKSA HHHHHHHHHHHHHHH | 33.00 | 26822725 | |
559 | Malonylation | QKLDAQVKELVLKSA HHHHHHHHHHHHHHH | 33.00 | 26320211 | |
559 | Ubiquitination | QKLDAQVKELVLKSA HHHHHHHHHHHHHHH | 33.00 | 23000965 | |
564 | 2-Hydroxyisobutyrylation | QVKELVLKSAVEAER HHHHHHHHHHHHHHH | 28.96 | - | |
564 | Acetylation | QVKELVLKSAVEAER HHHHHHHHHHHHHHH | 28.96 | 25953088 | |
564 | Malonylation | QVKELVLKSAVEAER HHHHHHHHHHHHHHH | 28.96 | 26320211 | |
564 | Ubiquitination | QVKELVLKSAVEAER HHHHHHHHHHHHHHH | 28.96 | 23000965 | |
576 | Acetylation | AERLVAGKLKKDTYI HHHHHCCCCCCCCEE | 47.60 | 25953088 | |
576 | Malonylation | AERLVAGKLKKDTYI HHHHHCCCCCCCCEE | 47.60 | 26320211 | |
576 | Ubiquitination | AERLVAGKLKKDTYI HHHHHCCCCCCCCEE | 47.60 | 33845483 | |
577 | Ubiquitination | ERLVAGKLKKDTYIE HHHHCCCCCCCCEEC | 9.02 | 21890473 | |
578 | Acetylation | RLVAGKLKKDTYIEN HHHCCCCCCCCEECC | 52.68 | 23749302 | |
578 | Ubiquitination | RLVAGKLKKDTYIEN HHHCCCCCCCCEECC | 52.68 | 21963094 | |
579 | Acetylation | LVAGKLKKDTYIENE HHCCCCCCCCEECCC | 66.78 | 26051181 | |
579 | Ubiquitination | LVAGKLKKDTYIENE HHCCCCCCCCEECCC | 66.78 | 21963094 | |
581 | Phosphorylation | AGKLKKDTYIENEKL CCCCCCCCEECCCCC | 34.97 | 28152594 | |
582 | Phosphorylation | GKLKKDTYIENEKLI CCCCCCCEECCCCCC | 19.17 | 28152594 | |
587 | 2-Hydroxyisobutyrylation | DTYIENEKLISGKRQ CCEECCCCCCCCCHH | 63.80 | - | |
587 | Acetylation | DTYIENEKLISGKRQ CCEECCCCCCCCCHH | 63.80 | 23954790 | |
587 | Malonylation | DTYIENEKLISGKRQ CCEECCCCCCCCCHH | 63.80 | 26320211 | |
587 | Ubiquitination | DTYIENEKLISGKRQ CCEECCCCCCCCCHH | 63.80 | 33845483 | |
592 | Ubiquitination | NEKLISGKRQELVTK CCCCCCCCHHHHHHH | 44.08 | 21890473 | |
598 | Phosphorylation | GKRQELVTKIDHILD CCHHHHHHHHHHHHH | 34.60 | 29496963 | |
598 | Ubiquitination | GKRQELVTKIDHILD CCHHHHHHHHHHHHH | 34.60 | 21890473 | |
599 | Ubiquitination | KRQELVTKIDHILDA CHHHHHHHHHHHHHH | 38.36 | 29967540 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPN1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
OS9_HUMAN | OS9 | physical | 18711132 | |
GRP78_HUMAN | HSPA5 | physical | 10588643 | |
STT3B_HUMAN | STT3B | physical | 22939629 | |
RPN2_HUMAN | RPN2 | physical | 22939629 | |
SSRG_HUMAN | SSR3 | physical | 22939629 | |
RSSA_HUMAN | RPSA | physical | 22939629 | |
TECR_HUMAN | TECR | physical | 22939629 | |
VDAC2_HUMAN | VDAC2 | physical | 22939629 | |
SND1_HUMAN | SND1 | physical | 22939629 | |
SGTA_HUMAN | SGTA | physical | 25416956 | |
UBQL1_HUMAN | UBQLN1 | physical | 25416956 | |
ATPG_HUMAN | ATP5C1 | physical | 26344197 | |
CALX_HUMAN | CANX | physical | 26344197 | |
CCD47_HUMAN | CCDC47 | physical | 26344197 | |
CLGN_HUMAN | CLGN | physical | 26344197 | |
CY1_HUMAN | CYC1 | physical | 26344197 | |
IDH3A_HUMAN | IDH3A | physical | 26344197 | |
COX2_HUMAN | COX2 | physical | 26344197 | |
NDUAC_HUMAN | NDUFA12 | physical | 26344197 | |
NDUB8_HUMAN | NDUFB8 | physical | 26344197 | |
PYC_HUMAN | PC | physical | 26344197 | |
PPIB_HUMAN | PPIB | physical | 26344197 | |
RAB2A_HUMAN | RAB2A | physical | 26344197 | |
RL35_HUMAN | RPL35 | physical | 26344197 | |
SSRA_HUMAN | SSR1 | physical | 26344197 | |
SSRD_HUMAN | SSR4 | physical | 26344197 | |
EFTU_HUMAN | TUFM | physical | 26344197 | |
UBC_HUMAN | UBC | physical | 26912900 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-187, AND MASS SPECTROMETRY. | |
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299, AND MASSSPECTROMETRY. |